🚀 VC round data is live in beta, check it out!
Organigram Global Valuation Multiples
Discover revenue and EBITDA valuation multiples for Organigram Global and similar public comparables like TerrAscend, Aurora Cannabis, High Tide, Ispire Technology and more.
Organigram Global Overview
About Organigram Global
Organigram Global Inc is a licensed cultivator of cannabis and manufacturer of cannabis-derived goods in Canada. It is is focused on producing high-quality cannabis for adult recreational consumers. It has also developed and acquired a portfolio of legal adult-use recreational cannabis brands, including Edison, Holy Mountain, Big Bag O’ Buds, SHRED, SHRED’ems, Monjour, Tremblant Cannabis, Trailblazer, BOXHOT and DEBUNK. Organigram operates facilities in Moncton, New Brunswick and Lac-Superieur, Quebec, with a dedicated edibles manufacturing facility in Winnipeg, Manitoba.
Founded
2010
HQ
Employees
1.2K
Website
Sectors
Financials (LTM)
EV
$193M
Organigram Global Financials
Organigram Global reported last 12-month revenue of $212M and EBITDA of $19M.
In the same LTM period, Organigram Global generated $83M in gross profit, $19M in EBITDA, and had net loss of ($844K).
Revenue (LTM)
Organigram Global P&L
In the most recent fiscal year, Organigram Global reported revenue of $189M and EBITDA of $14M.
Organigram Global expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $212M | XXX | $189M | XXX | XXX | XXX |
| Gross Profit | $83M | XXX | $65M | XXX | XXX | XXX |
| Gross Margin | 39% | XXX | 34% | XXX | XXX | XXX |
| EBITDA | $19M | XXX | $14M | XXX | XXX | XXX |
| EBITDA Margin | 9% | XXX | 7% | XXX | XXX | XXX |
| EBIT Margin | (3%) | XXX | (6%) | XXX | XXX | XXX |
| Net Profit | ($844K) | XXX | ($18M) | XXX | XXX | XXX |
| Net Margin | (0%) | XXX | (9%) | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Organigram Global Stock Performance
Organigram Global has current market cap of $193M, and enterprise value of $193M.
Market Cap Evolution
Organigram Global's stock price is $1.43.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $193M | $193M | 0.0% | XXX | XXX | XXX | $-0.13 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialOrganigram Global Valuation Multiples
Organigram Global trades at 0.9x EV/Revenue multiple, and 10.2x EV/EBITDA.
EV / Revenue (LTM)
Organigram Global Financial Valuation Multiples
As of April 6, 2026, Organigram Global has market cap of $193M and EV of $193M.
Equity research analysts estimate Organigram Global's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Organigram Global has a P/E ratio of (228.5x).
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $193M | XXX | $193M | XXX | XXX | XXX |
| EV (current) | $193M | XXX | $193M | XXX | XXX | XXX |
| EV/Revenue | 0.9x | XXX | 1.0x | XXX | XXX | XXX |
| EV/EBITDA | 10.2x | XXX | 14.2x | XXX | XXX | XXX |
| EV/EBIT | (32.8x) | XXX | (17.6x) | XXX | XXX | XXX |
| EV/Gross Profit | 2.3x | XXX | 3.0x | XXX | XXX | XXX |
| P/E | (228.5x) | XXX | (10.9x) | XXX | XXX | XXX |
| EV/FCF | (20.1x) | XXX | (10.9x) | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Organigram Global Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Organigram Global Margins & Growth Rates
Organigram Global's revenue in the last 12 month grew by 27%.
Organigram Global's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.1M for the same period.
Organigram Global's rule of 40 is 38% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Organigram Global's rule of X is 78% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Organigram Global Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 27% | XXX | 24% | XXX | XXX | XXX |
| EBITDA Margin | 9% | XXX | 7% | XXX | XXX | XXX |
| EBITDA Growth | 61% | XXX | 76% | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 38% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 78% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.2M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.1M | XXX | XXX | XXX |
| S&M Expenses to Revenue | 12% | XXX | 12% | XXX | XXX | XXX |
| G&A Expenses to Revenue | 21% | XXX | 23% | XXX | XXX | XXX |
| R&D Expenses to Revenue | 3% | XXX | 4% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 40% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Organigram Global Public Comps
See public comps and valuation multiples for other Cannabis comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| TerrAscend | XXX | XXX | XXX | XXX | XXX | XXX |
| Aurora Cannabis | XXX | XXX | XXX | XXX | XXX | XXX |
| High Tide | XXX | XXX | XXX | XXX | XXX | XXX |
| Ispire Technology | XXX | XXX | XXX | XXX | XXX | XXX |
| Ascend Wellness Holdings | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Organigram Global M&A Activity
Organigram Global acquired XXX companies to date.
Last acquisition by Organigram Global was on XXXXXXXX, XXXXX. Organigram Global acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Organigram Global
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialOrganigram Global Investment Activity
Organigram Global invested in XXX companies to date.
Organigram Global made its latest investment on XXXXXXXX, XXXXX. Organigram Global invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Organigram Global
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Organigram Global
| When was Organigram Global founded? | Organigram Global was founded in 2010. |
| Where is Organigram Global headquartered? | Organigram Global is headquartered in Canada. |
| How many employees does Organigram Global have? | As of today, Organigram Global has over 1K employees. |
| Who is the CEO of Organigram Global? | Organigram Global's CEO is James Yamanaka. |
| Is Organigram Global publicly listed? | Yes, Organigram Global is a public company listed on Nasdaq. |
| What is the stock symbol of Organigram Global? | Organigram Global trades under OGI ticker. |
| When did Organigram Global go public? | Organigram Global went public in 2014. |
| Who are competitors of Organigram Global? | Organigram Global main competitors are TerrAscend, Aurora Cannabis, High Tide, Ispire Technology. |
| What is the current market cap of Organigram Global? | Organigram Global's current market cap is $193M. |
| What is the current revenue of Organigram Global? | Organigram Global's last 12 months revenue is $212M. |
| What is the current revenue growth of Organigram Global? | Organigram Global revenue growth (NTM/LTM) is 27%. |
| What is the current EV/Revenue multiple of Organigram Global? | Current revenue multiple of Organigram Global is 0.9x. |
| Is Organigram Global profitable? | Yes, Organigram Global is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Organigram Global? | Organigram Global's last 12 months EBITDA is $19M. |
| What is Organigram Global's EBITDA margin? | Organigram Global's last 12 months EBITDA margin is 9%. |
| What is the current EV/EBITDA multiple of Organigram Global? | Current EBITDA multiple of Organigram Global is 10.2x. |
| What is the current FCF of Organigram Global? | Organigram Global's last 12 months FCF is ($10M). |
| What is Organigram Global's FCF margin? | Organigram Global's last 12 months FCF margin is (5%). |
| What is the current EV/FCF multiple of Organigram Global? | Current FCF multiple of Organigram Global is (20.1x). |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.